Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress

Abstract Background Myocardial infarction (MI) remains a leading cause of mortality globally, often resulting in irreversible damage to cardiomyocytes. Ferroptosis, a recently identified form of regulated cell death driven by iron-dependent lipid peroxidation, has emerged as a significant contributo...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Wu, Xueping Shen, Pan Lou, Dongyan Song
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-025-01102-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571572526776320
author Chang Wu
Xueping Shen
Pan Lou
Dongyan Song
author_facet Chang Wu
Xueping Shen
Pan Lou
Dongyan Song
author_sort Chang Wu
collection DOAJ
description Abstract Background Myocardial infarction (MI) remains a leading cause of mortality globally, often resulting in irreversible damage to cardiomyocytes. Ferroptosis, a recently identified form of regulated cell death driven by iron-dependent lipid peroxidation, has emerged as a significant contributor to post-MI cardiac injury. The endoplasmic reticulum (ER) stress response has been implicated in exacerbating ferroptosis. Methods Here, we investigated the potential of Dioscin, a natural compound known for its diverse pharmacological properties, in mitigating ferroptosis in cardiomyocytes following MI by targeting ER stress. Results In animal models subjected to MI, administration of Dioscin notably improved cardiac function, reduced infarct size by approximately 24%, and prevented adverse remodeling, highlighting its therapeutic potential. Through in vitro and in vivo models of MI, we demonstrated that Dioscin treatment significantly attenuates ferroptosis in cardiomyocytes, as evidenced by a decrease in lipid peroxidation by about 19% and preserved mitochondrial integrity. Moreover, Dioscin exerted its protective effects by inhibiting ER stress markers, such as the phosphorylation levels of PERK and eIF2α proteins, and the expression levels of BIP and ATF4 proteins, thus disrupting the ER stress-mediated signaling cascade associated with ferroptosis. Conclusion Overall, our findings suggested that Dioscin holds promise as a therapeutic agent against post-MI cardiac injury by mitigating ferroptosis via the suppression of ER stress. Further investigations into the precise molecular mechanisms and clinical translation of Dioscin’s cardioprotective effects are warranted, offering a potential avenue for novel therapeutic interventions in MI-related cardiac complications. Graphical Abstract
format Article
id doaj-art-33ebc15d71da4454999d4b94dc9f76ae
institution Kabale University
issn 1528-3658
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj-art-33ebc15d71da4454999d4b94dc9f76ae2025-02-02T12:29:21ZengBMCMolecular Medicine1528-36582025-01-0131111610.1186/s10020-025-01102-yDioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stressChang Wu0Xueping Shen1Pan Lou2Dongyan Song3The First People’s Hospital of Lin’an DistrictCenter of Prenatal Diagnosis Huzhou Maternity & Child Health Care HospitalThe Second People’s Hospital of AnjiThe First People’s Hospital of Lin’an DistrictAbstract Background Myocardial infarction (MI) remains a leading cause of mortality globally, often resulting in irreversible damage to cardiomyocytes. Ferroptosis, a recently identified form of regulated cell death driven by iron-dependent lipid peroxidation, has emerged as a significant contributor to post-MI cardiac injury. The endoplasmic reticulum (ER) stress response has been implicated in exacerbating ferroptosis. Methods Here, we investigated the potential of Dioscin, a natural compound known for its diverse pharmacological properties, in mitigating ferroptosis in cardiomyocytes following MI by targeting ER stress. Results In animal models subjected to MI, administration of Dioscin notably improved cardiac function, reduced infarct size by approximately 24%, and prevented adverse remodeling, highlighting its therapeutic potential. Through in vitro and in vivo models of MI, we demonstrated that Dioscin treatment significantly attenuates ferroptosis in cardiomyocytes, as evidenced by a decrease in lipid peroxidation by about 19% and preserved mitochondrial integrity. Moreover, Dioscin exerted its protective effects by inhibiting ER stress markers, such as the phosphorylation levels of PERK and eIF2α proteins, and the expression levels of BIP and ATF4 proteins, thus disrupting the ER stress-mediated signaling cascade associated with ferroptosis. Conclusion Overall, our findings suggested that Dioscin holds promise as a therapeutic agent against post-MI cardiac injury by mitigating ferroptosis via the suppression of ER stress. Further investigations into the precise molecular mechanisms and clinical translation of Dioscin’s cardioprotective effects are warranted, offering a potential avenue for novel therapeutic interventions in MI-related cardiac complications. Graphical Abstracthttps://doi.org/10.1186/s10020-025-01102-yDioscinFerroptosisEndoplasmic reticulum stressMyocardial infarction
spellingShingle Chang Wu
Xueping Shen
Pan Lou
Dongyan Song
Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
Molecular Medicine
Dioscin
Ferroptosis
Endoplasmic reticulum stress
Myocardial infarction
title Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
title_full Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
title_fullStr Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
title_full_unstemmed Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
title_short Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
title_sort dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
topic Dioscin
Ferroptosis
Endoplasmic reticulum stress
Myocardial infarction
url https://doi.org/10.1186/s10020-025-01102-y
work_keys_str_mv AT changwu dioscinpretreatmentamelioratesferroptosisincardiomyocytesaftermyocardialinfarctionviainhibitingendoplasmicreticulumstress
AT xuepingshen dioscinpretreatmentamelioratesferroptosisincardiomyocytesaftermyocardialinfarctionviainhibitingendoplasmicreticulumstress
AT panlou dioscinpretreatmentamelioratesferroptosisincardiomyocytesaftermyocardialinfarctionviainhibitingendoplasmicreticulumstress
AT dongyansong dioscinpretreatmentamelioratesferroptosisincardiomyocytesaftermyocardialinfarctionviainhibitingendoplasmicreticulumstress